OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CTMX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

CytomX Therapeutics (CTMX) Earnings Date & Reports

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CTMX is expected to report earnings to fall ∞% to -6 cents per share on November 06

CytomX Therapeutics CTMX Stock Earnings Reports

Q3'25

Est.

$-0.07

Q2'25

Beat

by $0.06

Q1'25

Beat

by $0.21

Q4'24

Beat

by $0.43

Q3'24

Beat

by $0.24

The last earnings report on August 07 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 266.33K shares outstanding, the current market capitalization sits at 370.23M.

View a ticker or compare two or three

Compare

CTMX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CTMX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTMX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

151 Oyster Point Boulevard

Phone

+1 650 515-3185

Employees

122

Web

https://www.cytomx.com